These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9559126)

  • 1. [Characteristics of effect of fibrinolysis system on ADP- and serotonin-dependent human thrombocyte aggregation].
    Men'shikov MIu
    Biull Eksp Biol Med; 1998 Feb; 125(2):158-61. PubMed ID: 9559126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various aspects of the platelets-urokinase interaction].
    Bastida E; Villaverde CA; Borruel MT; Valdecasas FG
    Arch Farmacol Toxicol; 1979 Dec; 5(3):270-1. PubMed ID: 397805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of thrombocyte aggregation in altering the fibrinolytic activity and nonenzymatic fibrinolysis of the blood plasma].
    Pastorova VE; Bazaz'ian GG; Romanovskiĭ AA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):58-61. PubMed ID: 6215958
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
    J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profibrinolytic and antifibrinolytic effects of platelets.
    Devine DV; Carter CJ
    Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of parmidine (pyridinolcarbamate) on thrombocyte aggregation, blood clotting and fibrinolysis].
    Mashkovskiĭ MD; Lakin KM; Ovnatanova MS; Shvarts GIa
    Biull Eksp Biol Med; 1976 Mar; 81(3):322-4. PubMed ID: 953280
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro aggregation of rat platelets by cumulative doses of ADP: influence of 3 antiaggregants and a protease inhibitor, aprotinin].
    Mary A; Cros G; Modat G; Lalaurie M
    C R Seances Soc Biol Fil; 1983; 177(3):320-31. PubMed ID: 6193845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of recombinant urokinase activator plasminogen on the platelet aggregation and increase of the intracellular calcium level].
    Zubkov AV; Bushueva TL; Minashkin MM; Gurskiĭ IaG; Men'shikov MIu
    Biull Eksp Biol Med; 1999 Sep; 128(9):339-43. PubMed ID: 10560061
    [No Abstract]   [Full Text] [Related]  

  • 11. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 11-deoxymisoprostol ethyl ether sodium salt on thrombocyte aggregation and prothrombin time].
    Gabdrakhmanova SF; Makara NS; Sapozhnikova TV; Baschenko NZh; Nazarov VS; Zarudiĭ FS
    Eksp Klin Farmakol; 2008; 71(2):40-2. PubMed ID: 18488906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
    Day JR; Haskard DO; Taylor KM; Landis RC
    Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary.
    Rinder HM
    Ann Thorac Surg; 2006 Feb; 81(2):624. PubMed ID: 16427863
    [No Abstract]   [Full Text] [Related]  

  • 16. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation.
    Nielsen VG; Cohen BM; Cohen E
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):75-81. PubMed ID: 16607085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metergoline: a strong inhibitor of rat thrombocyte aggregation "in vitro.".
    Doni MG
    Haematologica; 1980 Dec; 65(6):717-24. PubMed ID: 6790362
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
    Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E
    Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological activity of antithrombotic agents immobilized on polymer surfaces.
    Kim SW; Ebert CD; McRea JC; Briggs C; Byun SM; Kim HP
    Ann N Y Acad Sci; 1983; 416():513-24. PubMed ID: 6233925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.